cancer gene therapy (Genos Biosciences)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namecancer gene therapy (Genos Biosciences)
Drug Alias Namecancer gene therapy (Axys/Memorial Sloan-Kettering Cancer Center)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsColonic NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenos Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelera
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsColonic NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A